Mr. Gergen was appointed Chief Executive Officer of Poseida in February 2022 and named Chairman of the Board of Directors in February 2023. He joined Poseida in February 2018, initially serving as Chief Business Officer and Chief Financial Officer before being named President and Chief Business Officer in July 2020.
Mark Gergen is Executive Chairman of Poseida Therapeutics having previously served as… · Experience: Poseida Therapeutics, Inc. · Education: University of ...
Mark J Gergen
CEO of Poseida Therapeutics
Mark J. Gergen is currently the Executive Chairman at Poseida Therapeutics, Inc. and an Independent Director at Aristea Therapeutics, Inc. He previously ...
Mark J Gergen is Chairman at Poseida Therapeutics Inc. See Mark J Gergen's compensation, career history, education, & memberships.
Mark J. Gergen has 2 current jobs as President, Chief Business Officer and Director at Poseida Therapeutics and CEO at PSYLIN NEUROSCIENCES .
As Chief Executive Officer, President and Chairman at POSEIDA THERAPEUTICS, Mark J. Gergen J.D. made $3,818,018 in total compensation.
Mar 4, 2024 · The estimated Net Worth of Mark J Gergen is at least $703 Thousand dollars as of 15 January 2016. Mr Gergen owns over 15,000 units of Poseida ...
Mr. Mark J. Gergen, J.D. is the Executive Chairman of the Board of Poseida Therapeutics Inc.
*/imgres?imgurl=https://cdn.theorg.com/54c94208-38b5-41af-9459-4402fe061324_thumb.jpg&imgrefurl=https://theorg.com/org/poseida-therapeutics/org-chart/mark-j-gergen&h=200&w=200&tbnid=ijFEH-2Jeb1bGM&q=Mark+J+Gergen&tbnh=104&tbnw=104&usg=AI4_-kSfKj-UQoOAe45Z47MJEStGdnpz-Q&vet=1&docid=Isndy__wio2LfM&hl=en-US&sa=X&ved=2ahUKEwidqe_xouSIAxWiKRAIHTzqFi4Q9QF6BAgJEAQ)
*/imgres?imgurl=https://i1.rgstatic.net/ii/profile.image/278666744483864-1443450737567_Q512/Mark-Gergen-2.jpg&imgrefurl=https://www.researchgate.net/profile/Mark-Gergen-2&h=512&w=512&tbnid=2zmUFMLS9o56cM&q=Mark+J+Gergen&tbnh=131&tbnw=131&usg=AI4_-kQizsXMkr2w7CKTQNUc0NXp818dsQ&vet=1&docid=tyONUWO6A09bhM&hl=en-US&sa=X&ved=2ahUKEwidqe_xouSIAxWiKRAIHTzqFi4Q9QF6BAgJEAg)
*/imgres?imgurl=https://cdn.theorg.com/8ab68a2b-ec50-4be1-9ee8-401e3adc1176_thumb.jpg&imgrefurl=https://theorg.com/org/poseida-therapeutics/org-chart/mark-j-gergen&h=200&w=199&tbnid=SFN_82Ad_mCo3M&q=Mark+J+Gergen&tbnh=104&tbnw=103&usg=AI4_-kQb52zzOrMnXf-UUePq5fbEbnOucg&vet=1&docid=Isndy__wio2LfM&hl=en-US&sa=X&ved=2ahUKEwidqe_xouSIAxWiKRAIHTzqFi4Q9QF6BAgJEAo)
*/imgres?imgurl=https://media.glassdoor.com/people/sql/1361695/poseida-therapeutics-ceo1643842729509.png&imgrefurl=https://www.glassdoor.com/Overview/Working-at-Poseida-Therapeutics-EI_IE1361695.11,31.htm&h=100&w=100&tbnid=FZ_fyRKIrQF03M&q=Mark+J+Gergen&tbnh=82&tbnw=82&usg=AI4_-kRz2j3YIw4T094323P2yjRNSbmU0Q&vet=1&docid=b7Nx3gh0BgQRHM&hl=en-US&sa=X&ved=2ahUKEwidqe_xouSIAxWiKRAIHTzqFi4Q9QF6BAgJEAw)
*/imgres?imgurl=https://i1.sndcdn.com/artworks-sMEInFvXGCwhe4Gb-I1wS2Q-t500x500.jpg&imgrefurl=https://soundcloud.com/user-306573075/108-non-viral-cell-and-gene-therapy-mark-gergen-ceo-poseida-therapeutics-inc&h=500&w=500&tbnid=83Vru8KkvCfnTM&q=Mark+J+Gergen&tbnh=130&tbnw=130&usg=AI4_-kSRby1ymnERcP8F4dKQKj2AS9uA7Q&vet=1&docid=nAL-3dTRddHC3M&hl=en-US&sa=X&ved=2ahUKEwidqe_xouSIAxWiKRAIHTzqFi4Q9QF6BAgJEA4)